Skip to content

A Brain Imaging Study of Nicotine Release in Cigarette Smokers

A Brain Imaging Study of Nicotine Release in Cigarette Smokers

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00254358
Enrollment
0
Registered
2005-11-16
Start date
2007-04-30
Completion date
2007-04-30
Last updated
2008-07-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nicotine Dependence

Keywords

Nicotine, Dopamine, IBZM

Brief summary

Tobacco Smoking is the most prevalent addiction in society today causing directly major health hazards and sharing morbidity with other psychiatric disorders. Nicotine binds to acetylcholine receptors and thus elevates DA release and inhibits DA transport. There are few studies using advanced brain imaging techniques to investigate how nicotine releases dopamine in humans. These studies utilized dopamine displacement paradigms with \[11C\] Raclopride binding to D2 receptor in Positron Emission Tomography (PET). There is evidence that smokers (particularly those who enjoyed smoking) showed decreased \[11C\] Raclopride binding in the caudate/nucleus accumbens and putamen after smoking cigarettes. These results also indicated that the effects of nicotine on dopaminergic neurotransmission are mediated by pleasure and craving. We propose to investigate the effects of smoking a cigarette ad lib on dopamine release by using dopamine competition paradigm with \[I123\] IBZM in SPECT. Secondly, we will test the hypothesis that dopamine deficiency is a major vulnerability factor for smoking. This may provide further evidence that dopamine deficiency in some smokers pre-disposes them to enjoy and desire smoking cigarettes more than others.

Interventions

None listed

Sponsors

Herzog Hospital
CollaboratorOTHER
Hadassah Medical Organization
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
20 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Chronic smokers and healthy non-smokers.

Exclusion criteria

* Pregnant and breast feeding women. * Age below 20. * Neurological disorders. * Others drugs.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026